These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 12886829
1. [Autoimmune hemolytic anemia presenting during treatment of chronic hepatitis C with interferon alpha]. Rizzi R, Lucarella FP, Ruggieri GB, L'Abbate M. Ann Ital Med Int; 2003; 18(2):107-10. PubMed ID: 12886829 [Abstract] [Full Text] [Related]
3. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin. Cauli C, Serra G, Chessa L, Balestrieri C, Scioscia R, Lai ME, Farci P. Haematologica; 2006 Jun; 91(6 Suppl):ECR26. PubMed ID: 16785129 [Abstract] [Full Text] [Related]
4. [Autoimmune hemolytic anemia in chronic hepatitis C virus infection treated with alpha-interferon: a therapy-related event or extra-hepatic immunologic manifestation?]. Giannoccaro F, Pace L, Antonaci S, Schiraldi O. Recenti Prog Med; 1999 Nov; 90(11):592-4. PubMed ID: 10608148 [Abstract] [Full Text] [Related]
5. Interferon-α induced psoriatic arthritis and autoimmune hemolytic anemia during chronic hepatitis C treatment. Oliveira TL, Caetano AZ, Belem JM, Klemz BC, Pinheiro MM. Acta Reumatol Port; 2014 Nov; 39(4):327-30. PubMed ID: 25341062 [Abstract] [Full Text] [Related]
6. Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient? Hrstic I, Huic D, Bilusic M, Vucelic B. J Clin Gastroenterol; 2006 Apr; 40(4):367-8. PubMed ID: 16633111 [No Abstract] [Full Text] [Related]
7. Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. Gentile I, Viola C, Reynaud L, Borrelli F, Cerini R, Ciampi R, Piazza M, Borgia G. J Interferon Cytokine Res; 2005 May; 25(5):283-5. PubMed ID: 15871666 [Abstract] [Full Text] [Related]
8. Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin. Vilar FC, Castro Gd, Moya MJ, Martinelli Ade L, De Santis GC, Cozac AP, Figueiredo JF. Rev Soc Bras Med Trop; 2007 May; 40(6):678-80. PubMed ID: 18200424 [Abstract] [Full Text] [Related]
10. Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin. Sykia A, Gigi E, Sinakos E, Bibashi E, Bellou A, Raptopoulou-Gigi M. J Gastrointestin Liver Dis; 2009 Mar; 18(1):118-9. PubMed ID: 19337648 [No Abstract] [Full Text] [Related]
12. Hemolytic anemia provoked by recombinant alpha-interferon. Takase K, Nakano T, Hamada M, Shiraki K, Oohashi Y, Kihira T, Tameda Y. J Gastroenterol; 1995 Dec; 30(6):795-7. PubMed ID: 8963402 [Abstract] [Full Text] [Related]
13. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, Rizzetto M, Saracco G. Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995 [Abstract] [Full Text] [Related]
14. [Autoimmune hemolytic anemia reactivated by alpha-interferon therapy in a case of chronic active C-type hepatitis]. Katayama T, Naitou Y, Kusaka M, Ochiai S, Yoshida M, Kaito K, Masuoka H, Shimada T, Nishiwaki K, Kobayashi M. Rinsho Ketsueki; 1995 Apr; 36(4):339-46. PubMed ID: 7783339 [Abstract] [Full Text] [Related]
15. Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. Lambotte O, Gelu-Simeon M, Maigne G, Kotb R, Buffet C, Delfraissy JF, Goujard C. J Infect; 2005 Oct; 51(3):e113-5. PubMed ID: 16230187 [Abstract] [Full Text] [Related]
16. Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response. Hung CH, Lee CM, Lu SN, Wang JH, Chen CH, Hu TH, Kee KM, Chang KC, Tseng PL, Yen YH, Changchien CS. Liver Int; 2006 Nov; 26(9):1079-86. PubMed ID: 17032408 [Abstract] [Full Text] [Related]
17. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis. Dalekos GN, Christodoulou D, Kistis KG, Zervou EK, Hatzis J, Tsianos EV. Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):933-9. PubMed ID: 9872615 [Abstract] [Full Text] [Related]
18. Pegylated interferon de novo-induce autoimmune haemolytic anaemia in chronic hepatitis C patient. Said A, Elbahrawy A, Alfiomy M, Abdellah M, Shahat K, Salah M, Mostafa S, Elwassief A, Aboelfotoh A, Abdelhafeez H, El-Sherif A. BMJ Case Rep; 2011 Aug 11; 2011():. PubMed ID: 22688484 [Abstract] [Full Text] [Related]
19. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J. N Engl J Med; 1998 Nov 19; 339(21):1493-9. PubMed ID: 9819447 [Abstract] [Full Text] [Related]
20. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, Cohard M, Reynes M, Chevallier M, Ducerf C, Baulieux J, Geffner M, Albrecht JK, Bismuth H, Trepo C. Gastroenterology; 2003 Mar 19; 124(3):642-50. PubMed ID: 12612903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]